C0376452||DNA Methylation
C0041366||Biomarkers
C3665472||Chemotherapy
C0521982||Response
C1527249||Colorectal Cancer
C0013203||Resistance
C0016360||5-Fluorouracil
C0016360||5-Fluorouracil
C1527249||colorectal cancer
C1527249||colorectal cancer
C0376452||DNA methylation
C0277556||recurrent disease
C0013203||drug resistance
C0008972||study
C0376452||methylation
C1527249||colorectal cancer
C0041366||markers
C3665472||chemotherapy
C0521982||response
C0376452||DNA methylation
C1527249||colorectal cancer
C1880239||Illumina Infinium HumanMethylation450 Beadchip assay
C1527249||colorectal cancer
C0334227||cells
C0521982||response
C0016360||5-Fluorouracil
C0376452||global methylation
C0282639||HT29
C0085983||SW48
C0016360||5-Fluorouracil
C0376452||DNA methylation
C0049065||5-aza-2'-deoxycytidine
C0049065||5-aza-2'-deoxycytidine
C1254351||drug
C0456387||classes
C0007620||cell viability
C0376452||global methylation
C1979963||profiles
C2350277||genome-wide methylation study
C1527249||CRCs
C0376452||methylation
C1527249||CRCs
C0017337||methylated genes
C0017337||genes
C0243095||hyper
C0017337||genes
C0243095||hypomethylated
C0017337||hypermethylated and hypomethylated genes
C0376452||methylation
C0017337||hypermethylated genes
C1518102||MAPK signaling pathway
C0162638||apoptosis
C0017337||hypomethylated genes
C0037080||PI3K-AKT signaling pathway
C0049065||5-aza-2'-deoxycytidine
C0521982||response
C0016360||5-Fluorouracil
C1512773||growth inhibition
C0016360||5-Fluorouracil
C0085983||hypermethylated cell lines SW48
C0017337||genes
C1527249||CRCs
C0087111||therapeutic
C0013203||chemoresistance
C0376452||methylation
C0017337||CCNEI
C1413177||CCNDBP1
C1418756||PON3
C1425700||DDX43
C1413393||CHL1
C1527249||colorectal cancer
C1527249||colorectal cancer
C0049065||5-aza-2'-deoxycytidine
C0016360||5-Fluorouracil
C1518102||MAPK signaling pathway